Zhejiang Tailin BioEngineering Co.,Ltd

SZSE:300813.SZ

24.27 (CNY) • At close October 26, 2023
Overview | Financials

Numbers are in millions (except for per share data and ratios) CNY.

2024 Q32024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q12019 Q42019 Q32019 Q22019 Q12018 Q42018 Q32017 Q42017 Q22017 Q12016 Q42016 Q32016 Q22016 Q12015 Q42015 Q32015 Q22015 Q12014 Q42014 Q32014 Q22014 Q1
Revenue 85.34875.63580.00766.73860.63163.5478.947140.16388.01574.16571.535100.78871.42262.99548.04366.25247.78445.44640.75657.78240.51843.29639.33249.22641.47838.13431.64131.64128.16328.16327.72627.72625.64425.64417.76713.27916.35916.35913.39113.391
Cost of Revenue 45.22938.38544.0942.28829.94425.73237.71874.09741.86330.30131.00940.27827.9321.57818.19327.02617.28315.63514.40826.74614.95719.13215.95319.5616.23515.17612.51512.51511.30411.30411.6811.6810.31510.3157.2944.885.9475.9476.0246.024
Gross Profit 40.11937.2535.91624.45130.68837.80841.22866.06646.15243.86440.52560.5143.49341.41729.8539.22630.50129.81226.34731.03625.56124.16423.37929.66625.24322.95819.12619.12616.85916.85916.04716.04715.32915.32910.4728.39910.41110.4117.3687.368
Gross Profit Ratio 0.470.4930.4490.3660.5060.5950.5220.4710.5240.5910.5670.60.6090.6570.6210.5920.6380.6560.6460.5370.6310.5580.5940.6030.6090.6020.6040.6040.5990.5990.5790.5790.5980.5980.5890.6330.6360.6360.550.55
Reseach & Development Expenses 18.20215.62514.89610.27517.55816.62613.94519.42416.05215.2913.70118.96914.3712.4229.28711.7977.6459.6288.65311.9387.145.1815.0515.6917.69100000002.3522.3522.3522.3525.1555.1552.3242.324
General & Administrative Expenses 0-2.8437.456-18.25620.179-1.7398.098-11.46319.179-2.7416.22-9.47412.367-1.5736.043-10.1145.783-1.1266.467-7.554.203-1.6464.878-4.9462.173-16.7926.6036.6035.7025.7026.1086.1087.2787.278-2.7454.3935.0795.0794.4494.449
Selling & Marketing Expenses 011.1169.10914.36612.89210.3977.38315.71410.7658.6217.81817.0558.9656.0687.0539.6657.0916.6017.755.8675.5195.5958.8134.1355.4724.174.3374.3373.4243.4243.6713.6713.523.523.1442.2822.2392.2392.1092.109
SG&A 17.9219.53816.565-3.89133.0718.65815.4824.25129.9435.8814.0387.58121.3324.49613.096-0.44912.8735.47614.217-1.6839.7223.94913.692-0.8117.645-12.62210.9410.949.1279.1279.7799.77910.77510.7750.46.6757.2817.2816.5586.558
Other Expenses 0.008-0.2130.0760.012-0.4090.5360.0580.2520.019-0.0270.091-0.125-0.008-0.0480.032-0.0990.076-0.013-0.166-0.0010.0050.1150.0930.007-0.0061.92000000000.6630.8050000
Operating Expenses 36.11435.37729.17127.32734.74733.73225.95438.08632.3428.47228.18738.9328.28723.69720.84623.08916.03821.1419.09322.03816.15610.00717.6456.67914.21210.5458.9758.9758.0228.0228.3558.3559.3059.3058.3826.8636.4226.4225.8145.814
Operating Income 4.0051.8745.84-0.915-1.4916.12318.06130.10416.13118.57714.79922.89516.12919.90110.86917.85615.53810.0358.5019.1249.6213.8015.76722.44211.38712.3189.0989.0987.0367.0365.9635.9634.3774.3772.0671.6882.7352.7350.5450.545
Operating Income Ratio 0.0470.0250.073-0.014-0.0250.0960.2290.2150.1830.250.2070.2270.2260.3160.2260.270.3250.2210.2090.1580.2370.3190.1470.4560.2750.3230.2880.2880.250.250.2150.2150.1710.1710.1160.1270.1670.1670.0410.041
Total Other Income Expenses Net 1.382-0.58-0.831.984-0.4090.5360.0580.2520.019-0.0270.091-0.125-0.008-0.0480.032-0.0990.076-0.013-0.166-0.0010.0050.1150.0930.007-0.0061.9221.0541.0541.8021.8021.7541.7541.7491.7490.6630.8021.4561.4561.0411.041
Income Before Tax 5.3861.2935.916-0.903-1.96.65918.1230.35716.1518.5514.89122.7716.12119.85210.90117.75715.61410.0228.3349.1249.62513.9165.8622.44911.38214.2410.15210.1528.8378.8377.7187.7186.1266.1262.7312.494.1914.1911.5861.586
Income Before Tax Ratio 0.0630.0170.074-0.014-0.0310.1050.230.2170.1830.250.2080.2260.2260.3150.2270.2680.3270.2210.2040.1580.2380.3210.1490.4560.2740.3730.3210.3210.3140.3140.2780.2780.2390.2390.1540.1880.2560.2560.1180.118
Income Tax Expense 0.6530.9680.3751.4180.3411.2280.545-2.070.1891.1770.9651.6161.41.7971.3022.0661.214-0.9260.9870.0490.6472.6050.8172.4021.2641.8561.291.291.1071.1070.9360.9360.7240.7240.2630.3890.6070.6070.1080.108
Net Income 4.7330.7095.873-1.643-1.8825.61917.57532.42615.96117.37413.92521.15514.72118.0559.59815.6914.410.9487.3479.0758.97811.315.04320.04710.11812.3838.8628.8627.7317.7316.7826.7825.4025.4022.4682.1013.5833.5831.4781.478
Net Income Ratio 0.0550.0090.073-0.025-0.0310.0880.2230.2310.1810.2340.1950.210.2060.2870.20.2370.3010.2410.180.1570.2220.2610.1280.4070.2440.3250.280.280.2740.2740.2450.2450.2110.2110.1390.1580.2190.2190.110.11
EPS 0.0430.0070.05-0.014-0.0170.0520.160.30.130.160.210.20.140.170.0870.140.130.110.0720.110.110.140.0630.250.1300.230.230.190.190.180.180.0890.0890.10.10.2130.1810.0650.065
EPS Diluted 0.0430.0070.05-0.014-0.0170.0520.150.280.130.150.210.20.140.170.0870.140.130.110.0720.110.110.140.0630.250.1300.230.230.190.190.180.180.0890.0890.10.10.2130.1810.0650.065
EBITDA 9.2527.0826.9920.568-1.3816.47918.30831.10316.52617.20515.21428.62815.35119.6128.92322.16615.65311.7636.9629.1779.22914.0955.73523.62110.75312.8069.789.787.7177.7176.596.595.0465.0464.2882.0472.9242.9241.1171.117
EBITDA Ratio 0.1080.0940.0870.009-0.0230.1020.2320.2220.1880.2320.2130.2840.2150.3110.1860.3350.3280.2590.1710.1590.2280.3260.1460.480.2590.3360.3090.3090.2740.2740.2380.2380.1970.1970.2410.1540.1790.1790.0830.083